Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

BACKGROUND: In luminal androgen receptor (AR) tumours, FOXA1 may direct AR to sites occupied by ER in luminal tumours, thus stimulating proliferation. METHODS: AR and FOXA1 expression were evaluated by immunohistochemistry in 333 non-metastatic triple-negative breast cancers (TNBC). Positivity thres...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Cancer
Asıl Yazarlar: Guiu, Séverine, Mollevi, Caroline, Charon-Barra, Céline, Boissière, Florence, Crapez, Evelyne, Chartron, Elodie, Lamy, Pierre-Jean, Gutowski, Marian, Bourgier, Céline, Romieu, Gilles, Simony-Lafontaine, Joelle, Jacot, William
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6035246/
https://ncbi.nlm.nih.gov/pubmed/29880907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0142-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller